Subscribe Here!
    | 1 min read

    Guidelines Extend Thrombectomy Window to 24 Hours


     Written by MedStudy
    January 30, 2018

    “This will be perhaps a once in a lifetime situation where a study gets published [and] within 2 hours is incorporated into new guidelines.”

    The DEFUSE 3 Trial and the DAWN trial, released in 2017, provide overwhelming evidence that treating patients up to 24 hours after ischemic stroke can be safe and effective. The results of these trials resulted in rapid guideline updates by the American Heart Association and the American Stroke Association. Click on the link below for details about the new guidelines.

    Read original article...

    Related Categories

    CME & MOC Pediatrics Internal Medicine Guideline updates

    You may also like:

    CME & MOC

    4 Reasons Why ACCME Accreditation Matters

    In the ever-evolving field of medicine, continuing medical education (CME) plays a crucial role in keeping healthcare pr...

    CME & MOC

    5 Ways to Make Earning Medical CME & MOC More Than Just an Obligation

    Do you ever feel like your medical CME credits and MOC points are an obligation you’d rather not have to deal with? Some...

    CME & MOC Board prep

    5 Tips For Your Traditional ABIM Recertification Exam

    Key takeaways:

    MedStudy makes learning medicine easier. From board prep to continuing ed, wherever you are in your medical journey, our study solutions can help you succeed.
    © 2022 MedStudy Corporation. All Rights Reserved